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1. Introduction  
1.1 Primary healthcare and traditional medicine 
Primary Health Care (PHC) is the key to the development of a national health policy based 
on practical, scientifically sound and socially acceptable methods and technology made 
universally acceptable to individuals and families in the community and through their full 
participation and at a cost that the community and the country can afford, in order to 
maintain, at every stage of their development, in the spirit of self-reliance and self 
determination. It is the first level of contact for the individual, family and the community 
within the national health care system, bringing health care as close as possible to where 
people live and work and thus constitutes the first element of a continuing health care 
process (WHO, 1978a). A health system, based on primary health care was adopted as the 
means of achieving the goal of health for all. Most developing countries of the world, for 
which the scheme was designed, have failed to seriously implement it up till this moment.  
Traditional Medicine is defined by the World Health Organization (WHO, 1978a) as the sum 
total of knowledge or practices whether explicable or inexplicable, used in diagnosing, 
preventing or eliminating a physical, mental or social disease which may rely exclusively on 
past experience or observations handed down from generation to generation, verbally or in 
writing. It also comprises therapeutic practices that have been in existence often for 
hundreds of years before the development of modern scientific medicine and are still in use 
today without any documented evidence of adverse effects. The explicable form of 
Traditional Medicine can be described as the simplified, scientific and the direct application 
of plant, animal or mineral materials for healing purposes and which can be investigated, 
rationalized and explained scientifically. 
1.2 Herbal medicine 
The use of Salix alba, the willow plant (containing the salicylates) for fever and pains which 
led to the discovery of aspirin, would belong to this form of Traditional Medicine. Herbal 
medicines, which squarely belong to this form, are regarded by the World Health 
Organization, as finished and labeled medicinal products that contain, as active ingredients, 
aerial or underground parts of identified and proven plant materials, or combination 
thereof, whether in crude form or as plant preparations. They also include plant juices, 
gums, fatty oils, essential oils etc (WHO, 1978a). There are several other official modern 
drugs today, which were originally developed like aspirin through traditional medicine e.g. 
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morphine, digoxin, quinine, ergometrine, reserpine, atropine, etc and all of which are 
currently being used by orthodox medicine in modern hospitals all over the world.  
The inexplicable form of Traditional Medicine on the other hand, is the spiritual, 
supernatural, magical, occultic, mystical, or metaphysical form that cannot be easily 
investigated, rationalized or explained scientifically e.g. the use of incantations for healing 
purposes or oracular consultation in diagnosis and treatment of diseases. The explanation is 
beyond the ordinary scientific human intelligence or intellectual comprehension. Plants are 
reputed in the indigenous systems of medicine for the treatment of various diseases (Arise et 
al., 2009). Phyto-chemicals isolated from plant sources are used for the prevention and 
treatment of several medical problems including diabetes mellitus (Waltner- Law et al., 
2002). There are more than 800 plant species showing a hypoglycemic activity. The World 
Health Organization (1980) has also recommended the evaluation of the effectiveness of 
plants in conditions where safe modern drugs are lacked. 
2. Major groups of antimicrobial compounds from plants  
Plants have an almost limitless ability to synthesize aromatic substances, most of which are 
phenols or their oxygen-substituted derivatives (Geissman 1963). Most are secondary 
metaboltes, of which at least 12,000 have been isolated, a number estimated to be less than 
10% of the total (Schultes 178). In many cases, these substances serve as plant defense 
mechanisms against predation by microorganisms, insects, and herbivores. Some, such as 
terpenoids, give plants their odors; others (quinones and tannins) are responsible for plant 
pigment. Many compounds are responsible for plant flavor (e.g., the terpenoid capsaicin 
from chili peppers), and some of the same herbs and spices used by humans to season food 
yield useful medicinal compounds. 
Simple phenols and phenolic acids, The mechanisms thought to be responsible for phenolic 
toxicity to microorganisms include enzyme inhibition by the oxidized compounds, possibly 
through reaction with sulfhydryl groups or through more nonspecific interactions with the 
proteins (Mason and Wasserman 1987).Phenolic compounds possessing a C3 side chain at a 
lower level of oxidation and containing no oxygen are classified as essential oils and often 
cited as antimicrobial as well. Eugenol is a well-characterized representative found in clove 
oil. Eugenol is considered bacteriostatic against both fungi (Duke 1985) and bacteria 
(Thomson 1978). Quinones are aromatic rings with two ketone substitutions. They are 
ubiquitous in nature and are characteristically highly reactive. Probable targets in the 
microbial cell are surface-exposed adhesins, cell wall polypeptides, and membrane-bound 
enzymes. Quinones may also render substrates unavailable to the microorganism. As with 
all plant-derived antimicrobials, the possible toxic effects of quinones must be thoroughly 
examined.Kazmi et al.  
Flavones, flavonoids, and flavonols activity is probably due to their ability to complex with 
extracellular and soluble proteins and to complex with bacterial cell walls, as described 
above for quinones. More lipophilic flavonoids may also disrupt microbial membranes 
(Tsuchiya 1996). Tannins are found in almost every plant part: bark, wood, leaves, fruits, 
and roots (Scalbert 1991). This group of compounds has received a great deal of attention in 
recent years, since it was suggested that the consumption of tannin-containing beverages, 
especially green teas and red wines, can cure or prevent a variety of ills (Serafini et al 1994) 
their mode of antimicrobial action, may be related to their ability to inactivate microbial 
adhesins, enzymes, cell envelope transport proteins, etc. They also complex with 
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polysaccharide (Ya  et al 1988). The antimicrobial significance of this particular activity has 
not been explored. There is also evidence for direct inactivation of microorganisms: low 
tannin concentrations modify the morphology of germ tubes of Crinipellis perniciosa 
(Brownlee et al 1990). Tannins in plants inhibit insect growth (Schultz 1988) and disrupt 
digestive events in ruminal animals (Butler 1988). 
Terpenoids and Essential Oils are secondary metabolites that are highly enriched in 
compounds based on an isoprene structure. They are called terpenes, their general chemical 
structure is C10H16, and they occur as diterpenes, triterpenes, and tetraterpenes (C20, C30, and 
C40), as well as hemiterpenes (C5) and sesquiterpenes (C15). When the compounds contain 
additional elements, usually oxygen, they are termed terpenoids. The mechanism of action 
of terpenes is not fully understood but is speculated to involve membrane disruption by the 
lipophilic compounds. Accordingly, Mendoza et al. (Mendoza et al 1997) found that 
increasing the hydrophilicity of kaurene diterpenoids by addition of a methyl group 
drastically reduced their antimicrobial activity.  
Alkaloids are Heterocyclic nitrogen compounds. Alkaloids have been found to have 
microbiocidal effects (including against Giardia and Entamoeba species Ghosha et al 1996, the 
major antidiarrheal effect is probably due to their effects on transit time in the small 
intestine. Berberine is an important representative of the alkaloid group. It is potentially 
effective against trypanosomes (Freiburghaus et al 1996) and plasmodia Omulokoli et al 
1997). The mechanism of action of highly aromatic planar quaternary alkaloids such as 
berberine and harmane (Hopp 1976) is attributed to their ability to intercalate with DNA 
(Phillipson and O’Neill 1987). The mechanism of lectins and polypeptides may be back to 
the formation of ion channels in the microbial membrane (Terras et al. 1993) or competitive 
inhibition of adhesion of microbial proteins to host polysaccharide receptors (Sharon and 
Ofek 1986). Recent interest has been focused mostly on studying anti-HIV peptides and 
lectins, but the inhibition of bacteria and fungi by these macromolecules, such as that from 
the herbaceous Amaranthus, has long been known (De Bolle  et al 1996). 
2.1 Ethnobotanical study 
Out of around 1076 species recorded so far from Semifinal Biosphere Reserve, more than 200 
species are attributed with medicinal uses (Rout, 2004). This system of using herbs and 
different biological active ingredients in treating various diseases had become a part of their 
culture till recent years. Entrance of market economy gave rise to exploitation of natural 
resources and thereby depleting our resources base. The most affected part in this process 
was medicinal plants, which is most sensitive and delicate in the environment of forest. 
These medicinal plants gain further importance in the region where modern medical health 
facilities are either not available or not easily accessible. Although our ancient sages through 
hit and trial method developed herbal medicines, the reported uses of plant species do not 
certify efficacy.  
The present preliminary report on the uses of some plant species need to pharmacologically 
screened, chemically analyzed and tested for bioactive activities.  Pharmacological screening 
of plant extracts provides insight to both their therapeutic and toxic properties and helps in 
eliminating the medicinal plants or practices that may be harmful. The plant parts used for 
medical preparation were bark, flowers, rhizomes, roots, leaves, seeds, gum and whole 
plants. In some cases the whole plant including roots was utilized. The use of plant derived 
products containing high of dietary fiber and complex polysaccharide for the management 
of diabetes have been proposed (Jenkins et al., 1976). Natural products especially of plant 
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origin have been found to be potential sources of novel molecules for the treatment of 
diabetes (Farnsworth, 1994; Marles and Farnsworth, 1995). 
Considering the rate at which the vegetation is getting depleted in this part of the world, 
therefore it is needed to document the precious knowledge of these plants and to search for 
more plants with antidiabetic potential. The search for anti-diabetic agents has been focused 
on plants because of their ready availability, effectiveness, affordability and probably due to 
low side effects (Marles and Farnsworth, 1995). Ethnobotanical study has been the method 
often used to search for locally important plant species with low side effects especially for 
the discovery of crude drugs (Farnsworth, 1994). The present study therefore is a 
documentation of plants and plant parts used for the management of diabetes mellitus by 
traditional healers of the area (Table 1). 
 
Diagnosis methods Respondent (%) 
Signs and symptoms
Loss of body weight 
Body weakness 
Excessive urination 
Presence of sugar in urine 
Excessive thirsty 
100 
100 
100 
100 
53 
Duration of treatment 
Short duration
Long duration 
40
60 
Efficacy of plant treatment on patients 
Disappearance of sugar in urine 100
Reduction in body weakness 100 
Normal body weight 100 
Reduction in frequency of urination 
100
100 
100 
100 
Traditional healers claim of no adverse effect after treatment 
Yes
No 
100
0 
Traditional healers claim of total cure after treatment
Yes
No 
80
20 
Table 1. Diagnosis methods of diabetes mellitus by the herbalists using herbal preparation 
2.2 Diabetes mellitus  
2.2.1 What is Diabetes? 
The word “diabetes” (a Greek word that means “to pass through”) was first used by 
Aretaeous of Capadocia in the 2nd century AD to describe a condition that is characterized 
by excess of sugar in blood and urine, hunger and thirst (MacFrlance et al.,1997) and the 
adjective “mellitus” (a latin-greek word that means “honey”) was introduced by the English 
physician John Rollo so as to distinguish the conditions from other polyuric diseases, in 
which glycosuria does not occur (Rollo 1797). People suffering from diabetes are not able to 
produce or properly use insulin in the body and therefore chronic hyperglycemia occurs. In 
addition, the diabetic individual is prone to late onset complications (Fujisawa et al., 2004), 
such as retinopathy, neuropathy and vascular diseases, that are largely responsible for the 
morbidity and mortality observed in diabetic patients. 
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Diabetes mellitus is a chronic metabolic disorder characterized by widespread 
complications. It is the world’s largest endocrine disease associated with increased 
morbidity and mortality rates (Ghosh and Surawanshi, 2001). The chronic hyperglycemia of 
diabetes is associated with long-term damage, dysfunction and failure of various organs 
(Lyra et al., 2006). Liver involvement is one of the leading causes of death in diabetes 
mellitus. The mortality rate from the hepatic affection is greater than that from the 
cardiovascular complications. The spectrum of liver implication in diabetes ranges from 
non-alcoholic fatty liver disease to cirrhosis and eventually hepato-cellular carcinoma (Keith 
et al., 2004). Liver, an insulin-dependent organ, plays a pivotal role in glucose and lipid 
homeostasis. It participates in the uptake, oxidation and metabolic conversion of free fatty 
acids and in the synthesis of cholesterol, phospholipids and triglycerides.  
Several mechanisms are implicated in the pathogenesis of the functional and morphological 
alterations of the liver of diabetic patients (Brixova, 1981; Moller, 2001). There are two main 
types of diabetes, namely type I and type II (World Health Organization. Definition, 
Diagnosis and Classification of Diabetes mellitus and its omplications. Part 1: Diagnosis and 
Classification of Diabetes Mellitus (Department of Non communicable Disease Surveillance, 
Geneva, 1999)). Type I Diabetes, that is called insulin-dependent diabetes mellitus (IDDM) 
or juvenile onset diabetes develops when the body's immune system destroys pancreatic ┚- 
ells, the only cells in the body that produce the hormone insulin that regulates blood 
glucose. This type of diabetes usually strikes children and adults and the need for insulin 
administration is determinant for survival. Type I diabetes accounts for 5% to 10% of all 
diagnosed cases of diabetes and the risk factors may be autoimmune, genetic, or 
environmental.  
On the other hand, type II diabetes, also called non–insulin-dependent diabetes mellitus 
(NIDDM) or adult-onset diabetes, accounts for about 90% to 95% of all diagnosed cases of 
diabetes. It usually begins as insulin resistance, a disorder in which the cells do not use 
insulin properly and as the need for insulin rises; the pancreas gradually loses its ability to 
produce it. This type of diabetes is associated with older age, obesity, family history of 
diabetes, history of gestational diabetes, impaired glucose metabolism, physical inactivity, 
and race/ethnicity. It must be noted thought that in the last decay type II diabetes in 
children and adolescents is being diagnosed more frequently (Fagot-Gampagna & Narayan 
2001). In the case of the IDDM, insulin is of crucial importance for the survival of the 
patients. On the other hand, in the case of NIDDM the treatment includes medicines, diets 
and physical training.  
2.2.2 Ant diabetic medicines: Important medicinal plants used in diabetes treatment; 
important active 
2.2.2.1 Compounds involved in diabetes mellitus treatment 
Many kinds of antidiabetic medicines have been developed for the patients and most of 
them are chemical or biochemical agents aiming at controlling or/and lowering blood 
glucose to a normal level. Despite the impressive advances in health sciences and medical 
care, there are many patients who are using alternative therapies alone or complementary to 
the prescribed medication. Traditional plant remedies or herbal formulations exist from 
ancient times and are still widely used, despite all the controversy concerning their efficacy 
and safety (Huxtable 1990; Fugh-Berman 2000), to treat hypoglycemic and hyperglycemic 
conditions all over the world. 
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It must be noted that many ethno-botanical surveys on medicinal plants used by the local 
population have been performed in different parts of the world and there is a considerable 
number of plants described as antidiabetic. In addition a variety of compounds have been 
isolated (alkaloids, glycosides, terpenes, flavonoids, etc) but further studies need to be done 
so as these ‘leads’ to develop into clinically useful medicines. To date, met form in (a 
biguanide) is the only drug approved for treatment of type II diabetes mellitus. It is a 
derivative of an active natural product, galegine, isolated from the plant Galega officinalis L. 
(Witters 2001). The followinf table illustrate some of these plant involved in diabetes 
mellitus treatment 
 
Scientific 
name 
Family 
Active 
constituent 
Part Used Folk Medical Uses 
Abelmoschus 
moschatus 
Malvaceae myricetin aerial part
hypoglycemic action decrease 
the plasma glucose 
concentrations myricetin has an 
ability to enhance  glucose 
utilization to lower plasma 
glucose in diabetic rats with 
deficient insulin 
levels. 
Azadirachta 
indica 
Meliaceae  
dried 
powder of 
root and 
leaves 
caused significant lowering of 
blood sugar and reduction in 
serum lipids 
Cornus 
macrophylla 
Cornaceae   
prevent and treat diabetic 
complications 
Achyranthes 
aspera L. 
Amaranthaceae  
powdered 
whole 
plant 
hypoglycemic effect 
Achyrocline 
satureioides 
Asteraceae achyrofuran 
powdered 
whole 
plant 
lowered blood glucose levels 
Acosmium 
panamense 
Fabaceae  
water and 
butanolic 
extracts 
lowered the plasma glucose 
levels 
Aegle 
marmelose 
Rutaceae  leaf extract
similar hypoglycemic activity to 
that of insulin treatment 
Treatment with the leaf extract 
showed improved functional 
state of pancreatic ┚ cells. The 
results indicate the potential 
hypoglycemic effect of the leaf 
extract, possibly involved in 
processes for the regeneration of 
damaged pancreas. 
 
Table 2. Important medicinal Plants used in Diabetes treatment. 
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Scientific 
name 
Family 
Active 
constituent 
Part Used Folk Medical Uses 
Allium 
sativum L 
(Liliaceae allicine  
decreased the concentration of 
serum lipids, blood glucose and 
activities of serum enzymes like 
alkaline phosphatase, acid 
phosphatase and lactate 
dehydrogenase and liver 
G6Pase 
Allium 
cepa L. 
(Liliaceae 
S-methyl 
cysteine 
sulfoxide 
 
lowered the levels of 
malondialdehyde, 
hydroperoxide and conjugated 
dienes in tissues exhibiting 
antioxidant effect 
  (SMCS)  
on lipid peroxidation in 
experimental diabetes The 
hypoglycemic and 
hypolipidaemic actions of  
Allium cepa were associated 
with antioxidant activity, since 
onion decreased SOD activities 
while no increased lipid 
hydroperoxide and lipoperoxide 
concentrations were observed in 
diabetic rats treated with Allium 
cepa 
Aloe vera (Liliaceae  
leaf pulp 
and gel 
extracts 
contain a hypoglycemic agent 
which lowers the blood glucose 
levels showed hypoglycemic 
activity on type I and II diabetic 
maintained the glucose 
homeostasis by controlling the 
carbohydrate metabolizing 
enzymes 
(Rajasekaran et al., 2004). 
Aloe 
barbadensis 
Liliaceae  leaves 
the bitter principle may be 
mediated through stimulating 
synthesis and/or release of 
insulin from the ┚ cells of 
Langerhans 
Andrographis 
paniculata 
Acanthaceae andrographolide
crude 
ethanolic 
extract 
antidiabetic effect may be 
attributed, at least in part, to 
increased glucose metabolism 
andrographolide can increase 
the glucose utilization to lower 
plasma glucose in diabetic rats 
lacking insulin. 
 
 
Table 2. Important medicinal Plants used in Diabetes treatment. (continuation) 
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Scientific 
name 
Family 
Active 
constituent 
Part Used Folk Medical Uses 
Angylocalyx 
pynaertii 
Leguminosae 
sugar-mimic 
alkaloids 
pod 
extract 
specific inhibitors of alpha-L 
fucosidase with no significant 
inhibitory activity towards other 
glycosidases 
Areca catechu  arecolin  
Arecoline have hypoglycemic 
activity in animal model of 
diabetes upon s.c. 
administration 
Averrhoa 
bilimbi L. 
Oxalidaceae  
ethanolic 
extract 
ethanolic extract has 
hypoglycemic, 
hypotriglyceridemic, anti-lipid 
peroxidative and anti-
atherogenic properties in STZ-
diabetic rats. 
Bauhinia 
forficata L. 
Leguminosae kaempfer itr in 
n-butanol 
extract 
blood glucose-lowering effect in 
normal and diabetic rats 
Beta vulgaris L. 
var. cicla 
Chenopodiaceae
Betavulgaroside 
I, II, III and IV 
roots 
hypoglycemic effects that was 
demonstrated by a per os 
glucose tolerance test in rats 
after their per os administration 
Bidens pilosa Asteraceae 
3-beta-D-
glucopyranosylo
xy-1-hydroxy-
6(E)-tetradecene-
8,10,12-triyne 
Butanol 
extract of 
whole 
plant 
inhibited the differentiation of 
naive helper T cells (Th0) into 
Th1 cells but enhanced their 
transition into 
type II helper T (Th2) cells using 
an in vitro T cell differentiation 
assay 
Bryonia alba L. Curcubiaceae 
derivatives of 
trihydroxyoctade
cadienoic acid 
roots 
Restore the disordered lipid 
metabolism of alloxan-diabetic 
rats 
Bumelia 
sartorum 
Sapotaceae bassic acid 
ethanol 
extract of 
root bark 
altered glucose tolerance in 
alloxan-induced diabetic rats, 
enhanced glucose 
uptake in skeletal muscle and 
significantly inhibited 
glycogenolysis in the liver. 
Caesalpinia 
ferrea Mart 
Leguminosae 
ellagic 
acid and 2’-
(2,3,6-
trihydroxy-4-
carboxyphenyl)
ellagic aci 
 
might contribute to the relief of 
the long-term diabetic 
complications 
Camellia 
sinensis 
Theaceae 
epigallocatechin-
3-O-gallate 
 
may be beneficial in the 
prevention of diabetes mellitus 
Cassia tora  Fabaceae 
a-tocopherol, 
ascorbic acid and 
maltodextrin 
soluble 
fiber 
extracted 
improve serum lipid levels in 
type II diabetic subjects without 
serious 
adverse effects 
Table 2. Important medicinal Plants used in Diabetes treatment.( continuation) 
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Scientific 
name 
Family 
Active 
constituent 
Part Used Folk Medical Uses 
Cecropia 
obtusifolia 
Bertol 
Cecropiaceae 
isoorientin and 
3-caffeoylquinic 
acid 
water and 
butanolic 
extracts 
prepared 
from 
leaves 
beneficial effects on 
carbohydrate and lipid 
metabolisms when it was 
administered as an adjunct on 
patients with type II diabetes 
with poor response to 
conventional medical 
treatment. 
Cleome 
droserifolia 
(Capparidaceae) 
   
possessed a postprandial 
hypoglycemic effect but also 
suppressed the hepatic glucose 
release in the fasting state in a 
comparable way to this of 
insulin. The plant also 
possessed hypo-cholesterolemic 
effect, most pronounced on the 
LDL cholesterol. 
Cnidium 
officinale 
Makino 
Apiaceae   
inhibited the high 
glucoseinduced 
proliferation of GMCs partially 
through TGF-beta1 production 
Coccinia indica Cucurbitaceae  
ethanolic 
extract of 
Coccinia 
indica 
leaves 
normalized blood glucose and 
caused marked improvement of 
altered carbohydrate 
metabolizing enzymes during 
diabetes. 
Commelina 
communis 
Commeliaceae 
pyrrolidine 
alkaloid, 2,5-
dihydroxymethy
l-3,4-
dihydroxypyrrol
idine and four 
piperidine 
alkaloids, 1-
deoxymannojiri
mycin, 1-
deoxynojirimyci
n, alpha-
homonojirimycin
and 7-O-beta-D-
glucopyranosyl 
alpha-
homonojirimycin
 
 
 
methanolic 
extract 
inhibitoryactivity against  
alpha-glucosidase 
 
Table 2. Important medicinal Plants used in Diabetes treatment. (continuation) 
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Scientific 
name 
Family 
Active 
constituent 
Part Used Folk Medical Uses 
Croton cajucara Euphorbiaceae 
trans-
hydrocortin 
 
The mentioned compound also 
effectively lowered the blood 
sugar levels in glucose fed 
normal rats. 
Cryptolepis 
sanguinolenta 
Asclepiadaceae cryptolepine  
antihyperglycemic effect of 
cryptolepine leaded to a 
significant decline in plasma 
insulin concentration, associated 
with evidence of an 
enhancement in insulin 
mediated 
glucose disposal. Finally, 
cryptolepine increased glucose 
uptake by 3T3-L1 cells. 
Dioscorea 
dumetorum 
Dioscoreaceae dioscoretine 
methanol 
extrac 
normal and alloxan diabetic 
rabbits produced significant 
hypoglycemic effects and the 
hypoglycemic effects were 
compared to those of to 
butamide (Iwu et al., 1998) 
Galega 
officinalis L. 
Leguminosae Metformin  
Treat symptoms now ascribed to 
type II diabetes 
Gentiana 
olivieri Griseb 
Gentianaceae isoorientin  
Isoorientin exhibited significant 
hypoglycemic and 
antihyperlipidemic effects 
Gymnema 
sylvestre  
Asclepiadaceae gymnemic acid I
Water  
soluble 
extracts 
the leaves 
Gymnemic acids II and III 
showed potent inhibitory 
activity on glucose uptake. 
Hintonia 
latiflora 
Rubiaceae coutaraegenin  
coutareagenin, one of the active 
substances contained in the 
Hintonia latiflora bark, produces 
a reduction of 
the diabetic elevated blood 
sugar levels 
Hydnocarpus 
wightiana 
Arcariaceae 
Hydnocarpin, 
Luteolin, 
And 
isohydnocarpin 
acetone 
extract of 
the seed 
hulls 
the presence of antioxidant 
molecules along with their 
enzyme inhibitory activities in 
the acetone extract of 
Hydnocarpus wightiana seed 
hulls may be responsible for the 
antidiabetic 
Properties 
 
 
 
 
Table 2. Important medicinal Plants used in Diabetes treatment. (continuation) 
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Scientific 
name 
Family Active constituent
Part 
Used
Folk Medical Uses 
Lagerstroemia 
speciosa L. 
Lythraceae 
Lagerstroemin 
and flosin B 
hot-
water 
extract 
from 
banaba 
leaves
effects on controlling of the level 
of plasma glucose in type II 
diabetes mellitus. 
Larrea 
tridentata 
Zygophyllaceae masopropol  
lower plasma glucose 
concentration in two mice models 
of type II diabetes after per os 
administration (Luo et al., 1998) 
Myrcia 
multiflora 
Myrtaceae myrciacitrin I 
ethyl 
acetate-
soluble 
portion, 
show inhibitory activities on 
ALR2 and alpha-glucosidase as 
well as on the increase of serum 
glucose level in sucrose-loaded 
rats and in alloxan-induced 
diabetic mice (Yoshikawa et al., 
1998).
Paeonia 
lactiflora Pall. 
Panunculaceae paeoniflorin  
the mentioned glucoside reduced 
the elevation of blood sugar in 
glucose challenged rats. Increase 
of glucose utilization by 
paeoniflorin can thus be 
considered (Hsu et al., 1997). 
Pandanus 
odorus Ridl. 
Pantadaceae 
4-hydroxybenzoic 
acid 
 
4-hydroxybenzoic acid caused a 
decrease in plasma glucose levels 
dose-dependently. The compound 
did not affect serum insulin level 
and liver glycogen content in the 
diabetic model, but increased 
glucose consumption in normal 
and diabetic rat diaphragms. 
Phyllanthus 
sellowianus 
Euphorbiaceae 
isoqu ercitrin and 
rutin 
 
hypoglycemic and diuretic agent 
reduction in blood  
glucose levels
Pueraria 
thunbergiana 
Leguminosae kaikasaponin III  
kaikasaponin III (as a mixture of 
isomers), may exhibit its 
hypoglycemic and hypolipidemic 
effects by up-regulating or down-
regulating 
antioxidant mechanisms via the 
changes in Phase I and II enzyme 
activities .
Stevia 
rebaudiana 
Bertoni 
Compositae stevioside  
Stevioside was able to regulate 
blood glucose levels by enhancing 
not only insulin secretion, but also 
insulin utilization in insulin-
deficient rats; the latter was due to 
decreased PEPCK gene expression 
in rat liver by stevioside's action 
of slowing down Gluconeogenesis 
(Chen et al., 2005).
Table 2. Important medicinal Plants used in Diabetes treatment. (continuation) 
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Fig. 1. Some important active compound involved in diabetes mellitus treatment. 
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3. Some biomedical application for some plant used in treating hypoglycemic 
and hyperglycemic conditions 
A- Amelioration of hyperglycemia in STZ-diabetic rats. 
Several approaches were conducted in order to investigate the hypoglycemic and 
hypolipidemic activities of plant extract on experimental animals (STZ-diabetic rats). The 
derived data showed that some extracts are potent in the amelioration of hyperglycemia in 
STZ-diabetic rats and is a potential source for the isolation of new per os active agent(s) for 
anti-diabetic therapy like what observed in Averrhoa bilimbi ethanolic extract which has 
hypoglycemic, hypotriglyceridemic, anti-lipid peroxidative and anti-atherogenic properties 
in STZ-diabetic rats (Purshparaj et al., 2001). Another way was by the inhibition of 
myeloperoxidase activity and decreased lipid peroxidation, induced by ascorbyl radical 
either in microsomes or in asolectin and phosphatidylcholine liposomes as what observed in 
Bauhinia forficate due to the kaempferitrin effect .that showed high reactivity with the free 
radical 1,1-diphenyl-2-picryl hydrazyl (DPPH), 
In the plant Beta vulgaris L. var. cicla (Chenopodiaceae) the anti-diabetic effect  in 
experimental animals may be to the  reduction in  blood glucose levels by the regeneration 
of the ┚ cells (Bolkent et al., 2000). Betavulgarosides I, II, III, IV and oleanolic acid 
oligoglycosides produced hypoglycemic effects that was demonstrated by a per os 
glucose tolerance test in rats after their per os administration (Yoshikawa et al., 1996). Or 
through stimulating the synthesis/release of insulin from the ┚ cells of Langerhans like 
the effect of Biophytum sensitivum and/or also mediated through enhance secretion of 
insulin from the ┚ cells of Langerhans or through an Extra pancreatic mechanism 
(Catharanthus roseus L. (Apocynaceae)). Or by increasing the number of islet ┚ cells and that 
of islet ┙ cells was decreased in STZ-diabetic rats like what happen in Dendrobium 
candidum (Orchidaceae), Its mechanism of action probably involves the stimulation of the 
secretion of insulin from ┚ cells and the inhibition of the secretion of glucagons from ┙ 
cells and it can probably decrease the decomposition of liver glycogen and increase the 
synthesis of liver glycogen. 
The Administration of Coccinia indica (Cucurbitaceae) leaf extract, an indigenous plant used in 
Ayurvedic medicine in India, to normal and STZ-diabetic animals exhibited significant 
hypoglycemic and antihyperglycemic effect and reversed the associated with diabetes 
biochemical alterations (Venkateswaran & Pari 2002). The results indicated that the per os 
administration of Coccinia indica leaf extract to diabetic animals normalized blood glucose 
and caused marked improvement of altered carbohydrate metabolizing enzymes during 
diabetes. The antioxidant effects of an ethanolic extract of Coccinia indica leaves was 
studied in STZ-diabetic rats (Venkateswaran & Pari 2003). Per os administration of Coccinia 
indica leaf extract resulted in a significant reduction in thiobarbituric acid reactive 
substances and hydroperoxides and a significant increase in reduced GSH, SOD, CAT, 
glutathione peroxidase and glutathione-S-transferase in liver and kidney of STZ-diabetic 
rats, which clearly showed the extract’s antioxidant property. The ethnopharmacological use 
of Gongronema latifolium in ameliorating the oxidative stress found in diabetics and 
indicating promise of possible use in lessening morbidity in affected individuals. 
The obtained result by Kim et al 2006 suggest that the administration of Chrysanthemum 
coronarium and Morus alba, have a hypoglycemic effect in diabetic rats and their effect was 
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equivalent to that of glibenclamide. The administration of C.unshiu shows more 
antihyperlipidemic effect than antidiabetic effect. The effect of aqueous extracts from four 
medicinal plants on the blood glucose levels of experimental animals was determined at 
various time intervals for 9 h after oral administration at 100 mg dose kg-1 b.wt. (Fig. 2). 
There was a significant elevation in the blood glucose level by 3.3-5 times during 
experimental time period in alloxan-induced diabetic rats, when compared to normal rats. 
The administration of C. coronarium extract caused the blood glucose levels of diabetic rats 
to 83.4, 67.6, 75.1, 81.1 and 74.3% at the time interval of 1, 3, 5, 7 and 9 h, respectively 
(p<0.05). Maximum reduction of 32.4% was observed 3 h after treatment. The 
administration of M. alba extract produced the most significant reduction (p<0.05) among 
four medicinal plants in the blood glucose levels of 34, 41, 33 and 35% at 3, 5, 7 and 9 h 
respectively. 
 
 
Fig. 2. Percentage of effect of experimental plants on plasma glucose levels compared with 0 
h data in alloxaninduced diabetic rats (%). Values are mean percent of blood glucose 
concentration (n= 6). According to the study obtained by Kim et al., 2006. 
B- Hypoglycemic, hypolipidemic hypotriglyceridemic, anti-lipid peroxidative and anti-
atherogenic properties of these agents in different medicinal plant: 
Insulin resistance (hyperinsulinemia) is now recognized as a major contributor to the 
development of glucose intolerance, dyslipidemia and hypertension in type II diabetic 
patients. Aqueous extracts of Pterocarpus marsupium bark (Fbaceae) and Trigonella 
foenum-graecum. (Leguminosae) seeds have been shown to exert 
hypoglycemic/antihyperglycemic effect in experimental as well as in clinical settings 
(Grover et al., 2005). Results of this study, in addition to previous clinical benefits of 
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Pterocarpus marsupium seen in type II diabetic subjects, are suggestive of usefulness of its 
bark in insulin resistance, the associated disorder of type II diabetes. Though several 
antidiabetic principles (epicatechin, pterosupin, marsupin and pterostilbene) have been 
identified.  
The administration of trihydroxyoctadecadienoic acid and its derivatives obtained from 
the roots of the native Armenian plant Bryonia alba (Curcubiaceae) was found to restore the 
disordered lipid metabolism of alloxan-diabetic rats (Karageuzyan et al., 1998). These 
derivatives of trihydroxyoctadecadienoic acid can correct major metabolic abnormalities 
typical of severe diabetes mellitus they can influence the profile of the formation of stable 
prostaglandins by actions such as downstream of prostaglandin endoperoxides.  In 
Camellia sinensis (Theaceae) species, the blood glucose lowering activity of Camellia 
sinensis was studied by many workers. It has recently been reported that the major green 
tea polyphenolic constituent, epigallocatechin 3- gallate, mimics the cellular effects of 
insulin including the reductive effect on the gene expression of rate-limiting 
gluconeogenic enzymes in a cell culture system (Koyama et al., 2004). Per os 
administration of green tea that contains this polyphenolic constituent caused a reduction 
in the levels of mRNAs for gluconeogenic enzymes, PEPCK and G6Pase in the mouse 
liver. Epigallocatechin 3-gallate alone was also found to down-regulate the gene 
expression of these enzymes in vitro.  
Bumelia sartorum (Sapotaceae), the hypoglycemic effect may be similar to chlorpropamide and 
possibly due to an enhanced secretion of insulin from the islets of Langerhans or an 
increased utilization of glucose by peripheral tissues. Besides hypoglycemic activity, the 
ethanol extract also elicited significant anti-inflammatory activity, but did not show any 
significant effects on blood pressure, respiration or on the various isolated tissue 
preparations studied. Bassic acid, an unsaturated triterpene acid isolated from an ethanol 
extract of Bumelia sartorum root bark, elicited significant hypoglycemic activity in alloxan-
diabetic rats and altered the pattern of glucose tolerance in these animals when 
administered per os (Naik et al., 1991). In addition, bassic acid treatment increased 
significantly the glucose uptake process and glycogen synthesis in isolated rat diaphragm. 
Bassic acid treatment increased plasma insulin levels significantly in alloxandiabetic rats. It 
was therefore suggested that the hypoglycemia activity of bassic acid may be mediated 
through enhanced secretion of insulin from the pancreatic ┚ cells. 
Compelling evidence of Bidens pilosa (Asteraceae) suggests that infiltrating CD4 type I helper 
T (Th1) cells in the pancreatic islets play a pivotal role in the progression of diabetes in non-
obese diabetic mice. Treatment with a butanol fraction of Bidens blood glucose and insulin 
in non-obese diabetic mice in a dose-dependent manner and elevated the serum IgE levels 
regulated by Th2 cytokines (Chang et al., 2004). Moreover, the butanol fraction inhibited the 
differentiation of naive helper T cells (Th0) into Th1 cells but enhanced their transition into 
type II helper T (Th2) cells using an in vitro T cell differentiation assay. The butanol fraction 
of Biderns pilosa and its polyacetylenes can prevent diabetes possibly via suppressing the 
differentiation of Th0 cells into Th1 cells and promoting that of Th0 cells into Th2 cells. 
The results of a reported study of Gongronema latifolium (Asclepiadaceae) suggest that the 
extracts from leaves could exert their antidiabetic activities through their antioxidant 
properties (Ugochukwu & Bababy 2002). The aqueous and ethanolic extracts were tested in 
order to evaluate their effect on renal oxidative stress and lipid peroxidation in non-diabetic 
www.intechopen.com
       
Biomedical Science, Engineering and Technology 
 
182 
and STZ-diabetic rats after per os administration (Ugochukwu & Makini 2003). The 
ethanolic extract appeared to be more effective in reducing oxidative stress, lipid 
peroxidation, and increasing the GSH/GSSG ratio, The antihyperglycemic effects of 
aqueous and ethanolic extracts from Gongronema latifolium leaves was also investigated on 
glucose and glycogen metabolism in liver of non-diabetic and STZ-diabetic rats 
(Ugochukwu & Bababy 2003). The data showed that the ethanolic extract from the plant’s 
leaves had antihyperglycemic potency, which was suggested to be mediated through the 
activation of HK, PFK, G6PD and inhibition of GK in the liver. 
According to the study occurred by Mohammad Khalil, et al. (2010), it is found found that, 
the treatment of the diabetic rats with Citrullus colocynthis pulp extract, in the livers showed, 
more or less, an improvement in the histological architecture with persistence of the 
cytoplasmic vacuoles in some hepatocytes that could be attributed to the residual adverse 
effect of the diabetic affliction. But the noticed apparent general improvement signifies that 
Citrullus colocynthis could possess cyto-protective abilities on the hepatocytes. The present 
findings are supported by those announced by Aburjai et al. (2007) who confirmed the anti-
diabetic properties of Citrullus colocynthis extract. Also, Sebbagh et al. (2009) stated that this 
plant could improve the streptozotosin-induced diabetes in rats. Bujanda et al. (2008) owed 
the similar steatotic inhibitory effect of resveratol to inhibition of the tumor necrosis factor 
alpha production, lipid per-oxidation and oxidative stress.  
The damaged sinusoids, the aemorrhage and the inflammatory cell infiltration encountered 
in the liver of the diabetic animals, might be due to the hyperglycemic state. Seifalian et al. 
(1999), in an analogous study in rabbits, stressed on that the sinusoidal affection is 
correlated with the severity of fat accumulation in the parenchymal cells. According to the 
findings of Khan and Chakarabarti (2003); Hayden et al. (2005) and Ban and Twigg (2008), 
hyperglycemia is the main offending factor in the onset of the micro-vascular diabetic 
complications. Fortunately, following Citrullus colocynthis intake, in their study, the 
damaged sinusoids, the haemorrhage and the inflammatory cell infiltration subsided 
indicating a beneficial role of such a remedy. These findings are supported by those claimed 
by Alarcon-Aguilar et al. (2000). Despite the obvious antidiabetic effect of Citrullus 
colocynthis pulp extract, its use in normal rats, in the current work, caused hepatocytic 
poration and few hapatocytes had condensed or fragmented nuclei indicating minimal 
hepatotoxicity.  
This herbal therapy of Gymnema sylvestre (Asclepiadaceae) appears to bring about blood 
glucose homeostasis through increased serum insulin levels provided by 
repair/regeneration of the endocrine pancreas. Also, the effectiveness of the water extract 
from the leaves of Gymnema sylvestre, in controlling hyperglycemia was investigated in type 
II diabetic patients as conventional per os anti-hyperglycemic agents (Baskaran et al., 1990). 
The obtained data suggested that the ┚ cells may be regenerated / repaired in type II 
diabetic patients on the extract’s supplementation. This was supported by the raised insulin 
levels in the serum of patients after the supplementation. Furthermore, the 
antihyperglycemic action of a crude saponin fraction and five triterpene glycosides 
(gymnemic acids I-IV and gymnemasaponin V) derived from the methanol extract of leaves 
of Gymnema sylvestre was investigated in STZ-diabetic mice (Sugihara et al., 2000). 
The results indicated that insulin-releasing action of gymnemic acid IV, administered i.p., 
may contribute to the antihyperglycemic effect by the leaves of Gymnema sylvestre.  
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Fig. 3. Photomicrographs of the livers of control, Citrullus colocynthis- treated, diabetic and 
Citrullus colocynthistreated diabetic rats, H&E stain; (a) Liver of control rats, ×40; (b) Liver of 
Citrullus colocynthis treated rats, showing few hapatocytes had condensed or fragmented 
nuclei ×40; (c) Liver of diabetic rats, showing disorganized hepatic cords, reduced sinusoids 
and many hepatocytes having cytoplasmic vacuolization, ×20; (d) Higher magnification of 
(c), showing most hepatocytes with cytoplasmic vacuolar degeneration and pyknotic nuclei 
(arrows), ×40; (e) Liver diabetic rats, showing a central inflammatory cell infiltration (white 
arrows) and hepatocytes with cytoplasmic vacuolar degeneration and pyknotic nuclei (black 
arrows), ×40; (f) Liver of diabetic rats treated with Citrullus colocynthis, showing recovered 
hepatocytes with less cytoplasmic vacuolization compared with diabetic animals. Few 
hepatocytes with cytoplasmic vacuolization and pyknotic nuclei are still seen (arrows), ×40. 
According to the study occurred by Mohammad Khalil, et al. (2010). 
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Fig. 4. Scanning electron micrographs of livers of control and Citrullus colocynthis-treated 
rats. (a) SEM of the liverof control rats showing normal hepatic cord around a Central Vein 
(CV), ×450; (b) Larger magnification of (a) showing normal Sinusoids (S) and normal 
Hepatocytes (H) with normal intercellular boundaries (arrows), ×1500 (c); SEM of the liver 
of Citrullus colocynthis-treated rats, showing rows of Hepatocytes (H) containing few pores 
(white arrows). Note the blood Sinusoids (S) and the intercellular boundaries (black arrows), 
×1100; (d) Higher magnification of (c), showing blood Sinusoids (S), Hepatocytes (H), 
intercellular spaces (black arrows) and erythrocytes (R), ×1500. According to the study 
occurred by Mohammad Khalil, et al. (2010). 
Gymnemic acid IV may be an anti-obese and antihyperglycemic prodrug. The inhibitory 
activity of each triterpene glycoside on the glucose uptake in rat small intestine fragments 
was examined, in order to determine its impact on the increase of serum glucose level in 
glucose-loaded rats (Yoshikawa et al., 1997). It was found that Gymnemic acids II and III 
showed potent inhibitory activity on glucose uptake. Gymnemoside b and gymnemic acids 
III, V, VII were found to exhibit a little inhibitory activity against glucose uptake, and the 
principal constituents, gymnemic acid I and gymnemasaponin V, lacked this activity. It is 
noteworthy that, although Gymnema saponin constituents such as Gymnemic acids II and 
III show no effect on serum glucose levels in oral-loaded rats, they exhibit potent inhibitory 
activity on the glucose uptake and further studies need to be contacted. 
The hypoglycemic activity of a decoction from Juniperus communis (juniper berries) both in 
normal glycemic and in STZ-diabetic rats was studied (Sanchez et al., 1994). Juniper 
decoction decreased glycemic levels in normal glycemic rats through an increase of 
peripheral glucose utilization or a potentiation of glucose induced insulin secretion. 
The per os administration of the decoction to STZ diabetic rats resulted in a significant 
reduction both in blood glucose levels and in the mortality index, as well as the prevention 
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Fig. 5. Scanning electron micrographs of livers of diabetic and Citrullus colocynthis-treated 
diabetic rats. (a) SEM of the liver of diabetic rats showing degenerating Hepatocytes (H) 
having a plenty of lipid droplets (white arrows). Damaged blood Sinusoids (S) are also seen 
as well as some erythrocytes (R) are spread inside hepatocytes, ×450; (b) SEM of the liver of 
diabetic rats showing hemorrhage of erythrocytes (R) between Hepatocytes (H). Lipid 
degeneration (black arrows) of hepatocytes is also seen, ×450; (c) SEM of the liver of Citrullus 
colocynthis-treated diabetic rats, showing intact Hepatocytes (H) and blood Sinusoids (S). 
Only fewhepatocytes around the central vein have some vacuoles, ×450; (d) SEM of the liver 
of Citrullus colocynthis treated diabetic rats (300 mg) with higher magnification, showing 
intact Hepatocytes (H) and a Central Vein (CV) containing a lot of erythrocytes. A few 
hepatocytes around the central vein have a few lipid droplets (arrows), ×1100. According to 
the study occurred by Mohammad Khalil, et al. (2010).  
of the loss of body weight. This effect seemed to be mediated by the peripheral action of 
juniper while in Olea europaea (Oleaceae) plant species, the hypoglycemic activity may 
result from two mechanisms: (a) potentiation of glucose induced insulin release, and (b) 
increased peripheral uptake of glucose. 
The hypoglycemic effect of the rhizomes of Polygala senega (Polygalaceae) was proposed that 
after i.p. administration was without altering the insulin levels and with the need of the 
presence of insulin in order to act. In addition, one of the active components of this 
hypoglycemic effect was identified as a triterpenoid glycoside, senegin-II (as a mixture of 
isomers). Solanum lycocarpum (Solanaceae) has been widely employed for diabetes 
management, obesity and to decrease cholesterol levels. Some of the polysaccharides slowed 
gastric emptying and act on the endocrinous system affecting the liberation of 
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gastrointestinal hormones, lowering blood glucose levels. The hypocholesterolemic activity 
could be due to the increased fecal bile acid excretion as well as to the action of the short-
chain fatty acids, coming from fermentation, on the synthesis of deltaaminolevulinate and 
by the increase of the cholesterol 7-alpha-hydroxylase and 3-hydroxy-3-methylglutaryl CoA 
reductase synthesis (DalAgnol & Lino von Poser 2000). 
4. Conclusions and future directions   
Scientists from divergent fields are investigating plants anew with an eye to their 
antimicrobial usefulness. A sense of urgency accompanies the search as the pace of 
species extinction continues. Laboratories of the world have found literally thousands of 
phytochemicals which have inhibitory effects on all types of microorganisms in vitro. 
More of these compounds should be subjected to animal and human studies to determine 
their effectiveness in whole-organism systems, including in particular toxicity studies as 
well as an examination of their effects on beneficial normal microbiota. It would be 
advantageous to standardize methods of extraction and in vitro testing so that the search 
could be more systematic and interpretation of results would be facilitated. Also, 
alternative mechanisms of infection prevention and treatment should be included in 
initial activity screenings. Disruption of adhesion is one example of an anti-infection 
activity not commonly screened for currently. Attention to these issues could usher in a 
badly needed new era of chemotherapeutic treatment of infection by using plant-derived 
principles. 
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